This work was supported by the National Institute on Alcohol Abuse and Alcoholism Division of Clinical and Biological Research (Z1A AA 000466). The CAIS software was developed with support from Sean O&#39;Connor, Martin Plawecki, James Hays, and Victor Vitvitskiy from the Indiana Alcohol Research Center (P60 AA 07611). Martin Plawecki is also supported by NIAAA R01 AA027236. CAIS-PR paradigms were developed with further support from Ulrich Zimmermann and Vijay Ramchandani. The authors thank Dr. Mary Lee, Dr. Nancy Diazgranados, Dr. David T. George, and Nurse Practitioner LaToya Sewell for medical support and the monitoring safety of the participants, as well as Dr. Reza Momenan for operational support. The authors also would like to thank the staff of the 5-SW day hospital and 1-HALC alcohol clinic at the NIH Clinical Center. The authors thank the research assistants for their operational support of the study, including Molly Zametkin, Jonathan Westman, Kristin Corey, Lauren Blau, and Courtney Vaughan. Finally, the authors are grateful and appreciative for the clinical oversight and guidance from the late Dr. Daniel Hommer.

This protocol follows the guidelines of the National Institutes of Health&#39;s human research ethics committee.
1. Initial nursing measures and set-up
<ol>
	<li>Perform a breathalyzer test to ensure a zero BrAC.</li>
	<li>Take vitals of interest such as temperature, respiration rate, blood pressure, and heart rate. Confirm age and sex. Take height (cm) and weight (kg).</li>
	<li>Collect a urine sample for a urine drug screen for all participants. Run a urine beta-hCG pregnancy test for females. Ensure both are negative to continue the study.</li>
	<li>Provide participants with a standardized 350 kcal metabolic meal.</li>
	<li>Complete a brief medical history to determine any recent hospital visits, illnesses, new medications since their screening visit for any changes that may significantly impact their safety during the study and quality of the data collected.</li>
	<li>Administer a recent drinking history questionnaire to assess any changes in alcohol consumption since their screening visit.</li>
	<li>If there are any clinically significant medical findings, alert nursing and research staff.</li>
	<li>Insert a 20 G IV catheter into a vein in the antecubital fossa of the non-dominant arm for the alcohol infusion. Secure the positioning, Flush the indwelling catheter with a 5 mL of pre-filled saline flush, and cap the catheter.</li>
	<li>Confirm delivery of alcohol infusate, including participant name, age, sex, and date of expiration.</li>
	<li>Obtain aliquots from both IV bags and test the solution for correct alcohol concentration amount using a refractometer.</li>
	<li>Instruct the participant to void the bladder.</li>
	<li>Administer baseline measures of interest.</li>
</ol>
2. Set up IV pump
<ol>
	<li>Ensure the IV pump is plugged into an outlet.</li>
	<li>Connect the standard IV tubing to the infusion bags. Run the infusate through the entire length of the IV tubing using the IV pump to saturate the inner-tubing surface area and flush out any significant air bubbles.</li>
	<li>Choose enough tubing sets between the participant&#39;s arm to be infused and IV pump based on proximity to the bathroom so that the participant may use the restroom while remaining connected to the IV pump.</li>
	<li>Connect the ethernet cable from the computer to the pump.</li>
	<li>Switch on the pump by pressing the gray Power ON button on the upper right side.</li>
	<li>Press the Volume Infused button on the left side. Make sure the numbers read zero.</li>
	<li>If the numbers do not read zero, press the Clear button.</li>
	<li>Press the Options/Edit button. Press the number 4 to select the computer control option.</li>
	<li>Use the arrow buttons on the top row of the pump to select Yes and press Enter.</li>
	<li>Ensure that there is a Computer Control flashing on the top of the pump screen.</li>
</ol>
3. Set up the laptop (Figure 1)
NOTE: The sections below are performed using the software and the accessories associated with the CAIS system.
<ol>
	<li>Connect the Drink button that the participant uses to click for drinks into the USB portal closest to the participant.</li>
	<li>Ensure the Drink button is connected prior to opening the software, or the software will not detect the button.</li>
	<li>Insert the dongle.</li>
	<li>Select the drive to enter the password.</li>
	<li>Once the password has been accepted, open the drive titled SecuDrive to access the software.</li>
	<li>Double click the software icon.</li>
	<li>Click on File &#62; New Session</li>
	<li>Create a filename using desired participant number.</li>
	<li>Save the data to the desktop, not the dongle, as the software may overload the dongle and crash.</li>
	<li>Select the PR experiment from the drop-down menu labeled Select Experiment.</li>
	<li>When the set-up screen appears requesting further information on the participant, fill in the fields requesting participant identification number, select &#34;Standard&#34; as study type, then enter sex and age in the appropriately labeled fields.</li>
	<li>Enter height (cm) and weight (kg) in the required fields using the data collected earlier in the visit.</li>
	<li>Click on the Submit button. 
	NOTE: The graph panel and the &#34;welcome&#34; window for the participant will now appear on the screen.</li>
	<li>Move the window over to the participant&#39;s monitor by clicking and dragging across the screen. Enlarge to full screen so the participant can see it.</li>
</ol>
4. Progressive Ratio (PR) self-administration session (Figure 2)
<ol>
	<li>Offer participants a bathroom break before beginning. Afterward, connect IV tubing from the infusion bags to the participant. Read instructions to the participant. 
	NOTE: Instructions should include what participants are not allowed to do (i.e., read, do work, use their phone), what will happen during the experiment, such as serial measures collected, and any information regarding the increasing work scale for receiving drinks.</li>
	<li>On the laptop, click on the Start/Run button at the top of the screen. 
	NOTE: A prompt appears on the participants&#39; monitor, informing them to click the Drink button for their priming rewards.</li>
	<li>Instruct the participant to press the Drink button as soon as the monitor prompts them to for their four individually standardized priming doses. Remind the participant to begin pressing the Drink button each time the screen prompt appears so that they reach their expected BrAC within 10 min. 
	NOTE: The entire priming phase should last 10 min. The doses require 2, 4, 7, and 10 button presses respectively in order to reach approximately 30 mg/dL (0.030 g/dL).</li>
	<li>At the 10 min mark (immediately following the last priming drink), collect the BrAC and blood pressure. Administer the subjective response measures.</li>
	<li>Enter the BrAC into the software by pressing Ctrl + B and typing in the value (i.e., 0.030). This will cause the algorithm to adjust if need be. Repeat this step every time a BrAC is collected.</li>
	<li>Allow the participant to rest for 10 min. 
	NOTE: The infusion system will continue to deliver the infusate with a rate profile that achieves a linear descent in BrAC and will not count any button pushes until the ad-lib phase begins.</li>
	<li>At the 20 min mark, collect the BrAC and blood pressure. Administer the subjective response measures.</li>
	<li>At the 25 min mark, inform the participant that the bar is open and include any further instructions required for the experiment. Do not interrupt work efforts when collecting measures from the participant. 
	NOTE: This instruction marks the transition from the priming to voluntary self-administration phase; participants are now working towards earning a reward any time and rate they wish or to pause or stop. Each drink requires increasing numbers of button presses before the reward is initiated.</li>
	<li>At the 45 min mark, collect the BrAC, blood pressure, and subjective response measures.</li>
	<li>Continue to collect subjective response measures, blood pressure, and BrAC every 15 min until the 165 min mark.</li>
	<li>Enter BrAC measures immediately into the system to adapt to any modeling errors.</li>
</ol>
5. End of session
<ol>
	<li>Click the Data tab on the software and select Export. 
	NOTE: The system will create a .CAS file of all time-stamped data relevant to the experiment, including participant number, dates, morphometric data, PBPK parameters, BrAC trajectory, infusion rate profile, BrAC measurements, button push history, alcohol used, bathroom breaks, and any technician comments entered during the session. The .CAS file is write-protected but can be used to replay the session at any future date.</li>
	<li>Remove the IV catheter.</li>
	<li>Press the Volume Infused button on the left side of the pump to see the values.</li>
	<li>Record the total volume of infusate used on the flowsheet.</li>
	<li>Remove the IV catheter.</li>
	<li>Continue to collect BrAC every 15-30 min until BrAC is below 20 mg/dL (0.02), or until the study-specific discharge criteria are met. 
	&#8203;NOTE: The protocol ends here. The following steps are for potential troubleshooting issues and data analysis.</li>
</ol>
6. Drink button troubleshooting
<ol>
	<li>Do not stop the session if the Drink button loses connection with the software and no longer responds to a press.</li>
	<li>Remove the Drink button from the port and place it in a different port on the computer. 
	NOTE: The original port is no longer recognized by the software.</li>
	<li>Click View on the software screen, scroll to the bottom, and select Map Drink Buttons.</li>
	<li>After a pop-up window appears on the screen, select the Drink button (signaling the software its new location) so that the address of the button&#39;s new location is entered for the Drink button.</li>
	<li>Select OK on the pop-up window on the computer screen.</li>
	<li>Press the Drink button again, and let the participant accept the drink.</li>
</ol>

Investigators interested in adapting the software to their own research should contact the corresponding author and Dr. Martin Plawecki. CAIS is not a free software. The authors declare no competing financial interests.

This protocol provides evidence that a progressive-ratio intravenous alcohol self-administration procedure successfully measures motivation for alcohol consumption in humans. The methodology extends the original pre-clinical progressive-ratio model into humans37. Test-retest results indicate that this paradigm provides a reliable protocol to test motivation for seeking alcohol across repeated visits. This protocol is also sensitive to variability in alcohol consumption behavior during a session, measures that may have the potential to influence motivation for alcohol, such as alcohol expectancies, and to associate differences in recent drinking history and may reflect the within-session subjective responses to alcohol. Support for the effectiveness of this procedure has also been published elsewhere, showing greater subjective response in terms of desire for more alcohol27,28,29,38 and greater consumption of alcohol39.
Because intravenous administration of alcohol is coupled with individualized PBPK-based computations of the infusion rate, a significant improvement upon oral alcohol methods (which can have a 3-4-fold difference) is achieved19. CAIS significantly reduces these interindividual differences in the distribution and elimination of alcohol by bypassing gastrointestinal absorption. Using the afore-mentioned PBPK model-based algorithm20, the system then prescribes the incremental trajectory of BrAC, which can then be adjusted by the investigator for their specific protocol22,23,27.
This protocol provides a platform for alcohol consumption that is simple to modify to match the characteristics being studied in the participant group and can be adjusted to reflect the question of interest. For example, the inclusion of a priming phase was specific to this study; other options are to remove the priming phase or to provide a specific target level or exposure. Such modifications include adjustments to the reward properties, the work required to achieve a reward, the timing of alcohol delivery, the length of the study, safety cut-off, and the ability to include an alternative reward, commonly placebo (e.g., saline).
In experiments using ingestion of alcohol, attention to safety concerns limits the amount of alcohol available to the participant for delivery over the course of a study; the resulting peak BrAC is typically much lower than a participant would consume outside of the laboratory. Using intravenous infusion combined with individualized, real-time PBPK modeling of the future trajectory of BrAC, the system controls the exposure. A safety limit can be prescribed, and all participants have access to peak BrACs typical of binge drinking if they choose. Currently recommended safety limits are 120 mg/dL in moderate drinkers, 150 mg/dL in heavy drinkers, and 180 mg/dL in dependent drinkers. In the free access paradigm, some drinkers will still reach and maintain these limits. In the PR paradigm, the peak BrAC exposure can be limited by specifying the sequence of work set requirements, given the incremental reward exposure chosen. By using a progressive-ratio method, the outcome used to measure the desire for alcohol is the amount of work produced to receive an exposure to alcohol satisfying that desire. Additionally, the measure of false button presses may be a limitation. Other factors can influence the number of false button presses, such as fatigue, the type of button used (our button versus a click on a mouse), or alcohol intoxication. Variations of this approach as applied by Plawecki et al. have been used to overcome this limitation using a modified PR task called the Constant Attention Task (CAT)25,26.
The most important limitation is the lack of a naturalistic setting as this procedure is typically done in a hospital or laboratory setting and uses a method of alcohol administration outside of the participant&#39;s experience. More beneficially, by eliminating environmental cues for alcohol consumption, these constraints allow the experimenters the flexibility of introducing those elements back into the experiment. For example, the computer screen can be formatted to include a bar setting, the room where the experiment is conducted could be changed to appear more like a bar, olfactory cues of alcohol or visual cues of alcohol can be introduced as well.
The significance of this method is that it provides direct control of incremental BrAC exposure, yielding range and flexibility in terms of alcohol delivery that oral alcohol methods cannot provide. Importantly, this progressive-ratio intravenous alcohol self-administration paradigm translates work effort into exposures that are consistent within and across participants and produce easily measurable outcomes. The set-up file defining work sequences and incremental reward exposures is simple to modify and tailor for experiments. An alternative method for prescribing work that uses IV alcohol and progressive ratio includes an attention component25,26. This method requires the participant to work for the alcohol-based on performing a task that requires constant attention to perform successfully. This method adapts to compensate for both the effects of alcohol as well as fatigue.
One of the most important applications for this method is medications development in the laboratory setting. The application of this system to relevant clinical populations is a highly promising and important direction to determine the effectiveness of medications on motivation for alcohol rewards. Test-retest of this protocol supports the reliability of the measures, while progressive ratio eases the concern of heavier drinkers reaching the BrAC ceiling while maintaining a measure directly addressing motivation for seeking alcohol. Furthermore, the use of this protocol may provide a better opportunity to examine genetic and environmental determinants of alcohol seeking.

The addictive properties of drugs can be evaluated using self-administration paradigms. Self-administration paradigms have been used to study the development of alcohol dependence in animal models1,2,3, as well as the effectiveness of medications used to treat alcohol dependence by reducing drinking in individuals4,5,6. In order to assess the motivational properties of alcohol, a progressive ratio (PR) schedule paradigm was developed using intravenous alcohol. PR schedules require a pre-defined, increasing amount of work to obtain the next reward. The last completed level of work to obtain a reward (total rewards earned) is called the breaking point (BP). Thus, BP is a measure of the motivation for that reinforcer.
Pre-clinical investigations have used the PR schedule paradigm to assess a variety of factors involved in the motivation to work for ethanol, such as sigma receptors7,8, glucocorticoid receptor9, genetic determinants10, as well as screening for molecular targets for medication development11. Human studies have been less extensive in their use of the PR paradigm to characterize the motivation for seeking alcohol, although it has been used to study other drugs of abuse such as heroin and cocaine12,13.
Human alcohol studies employing a PR schedule have mostly used oral alcohol self-administration methods, examining the effect of naltrexone14, as well as the role of dopamine15 and nicotine16 in alcohol self-administration. In these studies, alcohol is typically administrated by ingestion of a mixture of alcohol at various concentrations in a variety of vehicles and is often conducted in a &#39;laboratory bar setting&#39;. They offer either &#34;standardized drinks&#34; that contain fixed amounts of alcohol per drink or body weight-adjusted amounts of alcohol per drink4,5,6,17,18, generally setting a maximal exposure. The ingestion PR paradigms encounter several difficulties related to dosing. Substantial variability in the absorption and lesser amounts in the distribution and metabolism of alcohol across participants means that the incremental BrAC trajectory following consumption of each reward cannot be controlled or standardized. The amount of alcohol provided must be limited so that the cumulative BrAC of the fastest absorber does not exceed safe limits19. The motivation to seek alcohol is also subject to variation in the participants&#39; expectations and experience regarding the beverage characteristics employed.
An alternative approach includes the intravenous (IV) administration of alcohol. The intravenous alcohol self-administration system method described here uses a physiologically-based pharmacokinetic (PBPK) model to continuously compute the precise rates of infusion required to produce a specified BrAC. The PBPK model&#39;s parameters are individualized, based on known values of age, sex, height, and weight. Compensation for individual differences in the pharmacokinetics of alcohol, and avoidance of the variability in absorption, enables the direct control of incremental exposure to alcohol rather secondarily through its dosing. This real-time adjustment provides the experimenter with control over the time course of a person&#39;s incremental BrAC to any desired rate, level, and duration of exposure20,21. The incremental exposures are the same for every participant, yielding a paradigm in which variation in the overall trajectory reflects variation in the participant&#39;s motivation rather than pharmacokinetic variations. Since this intravenous alcohol self-administration system computes the future time course of BrAC in real-time, initiation of a reward that would exceed a preset safety limit can be precluded22. Thus, every participant enjoys safe access to the entire range of exposure designed into the experiment. With IV administration, the participant also has no experience on which to base expectations of the consequence of drinking other than the effect of alcohol.
Prior intravenous alcohol self-administration studies using a free-access paradigm demonstrated high variability between individuals in self-administration behavior23 and high test-retest reliability in repeated sessions in healthy non-dependent drinkers24. Intravenous alcohol self-administration was used in a pilot study that employed an attentional task as the form of work required. The study concluded that the paradigm is effective for detecting an interaction between genotype and lorazepam treatment in the motivation for seeking alcohol25. Subsequent work identified sex differences in response to abstinence26. This model has shown to be a human translational parallel model for pre-clinical &#34;wanting&#34; behaviors27. Another study using this system demonstrated that those induced in a negative mood condition who exhibited greater negative urgency scores had a higher breakpoint and higher cumulative work with gender-specific effects28,29.
In the current study, BrAC rewards were delivered by infusing a 6% V/V ethanol solution through a vein in the ante-cubital fossa of the elbow30. Work was defined by the number of button presses necessary to receive an incremental increase in BrAC. The number of button presses increased for each subsequent reward. By the time the participant was working for their 10th reward, s/he was required to press the button 1,600 times, and for the 15th, almost 10,000 times. Each reward comprised a 7.5 mg/dL increase over the current BrAC, ascending at the rate of 3.0 mg/dL per minute for 2.5 min, then descending at the rate of -1.0 mg/dL per minute until the next reward was initiated. The first 25 min comprised four priming exposures prompted 2.5 min apart, i.e., receiving all four priming exposures within the first 10 min, resulting in a peak BrAC close to 30 mg/dL. This procedure allowed the participant to experience an alcohol reward as well as practice using the button. Then the participant rested for 15 min. Following this 25 min priming interval, an ad-lib PR period lasting 2 h began. Measures of self-administration included: average and peak BrAC, total rewards earned, total grams of EtOH consumed per unit of total body water, the total number of button presses, and the average rate of button pressing.
To date, there have been a small number of studies on PR schedules with alcohol in humans and fewer using IV alcohol. Therefore, the study aimed to develop a model with a PR schedule using a computer-assisted self-administration system that humans would respond to. The second aim was to evaluate the test-retest reliability of PR alcohol measures such as BrAC exposure resulting from alcohol self-administration behavior and response in non-dependent healthy participants. The third aim was to examine the influence of recent drinking history and sex on this alcohol self-administration behavior. Because the incremental BrAC exposure was the same across participants, the influence of these factors could be assessed, as well as individual responses to alcohol. Other factors of interest were personality and expectancy measures.
By demonstrating the repeatability of the individual&#39;s response to the PR schedule and its sensitivity to various determinants (such as recent drinking history), this paradigm can be qualified to evaluate the efficacy of medications on motivation for alcohol use disorder, as well as the role of genetics in alcohol use disorder. This laboratory approach would improve the understanding of both genetic and environmental determinants of alcohol self-administration behavior and motivation to consume alcohol.

<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td>Alcohol Infusate</td>
			<td>AKORN Pharmaceuticals</td>
			<td>https://www.akorn.com/</td>
			<td>95% ethanol solution can be purchased and diluted to 6% V/V ethanol solution. Must contact company for a quote</td>
		</tr>
		<tr>
			<td>Breath Alcohol Meter&#160; Draeger models 6820 or 5820</td>
			<td>Draeger Safety Diagnostics</td>
			<td>https://www.draeger.com/en-us_us/Applications/Products/Breath-Alcohol-and-Drug-Testing/Alcohol-Screening-Devices/Alcotest-6820; https://www.draeger.com/en-us_us/Applications/Products/Breath-Alcohol-and-Drug-Testing/Alcohol-Screening-Devices/Draeger-Alcotest-5820</td>
			<td>To collect breathalyzer readings</td>
		</tr>
		<tr>
			<td>Computer-assisted Alcohol Infusion System (CAIS)</td>
			<td>Indiana University</td>
			<td></td>
			<td>To adapt CAIS for one&#39;s own research aims, contact the corresponding author Dr. Bethany Stangl and Dr. Martin Plawecki</td>
		</tr>
		<tr>
			<td>Digital Refractometer</td>
			<td>Atago</td>
			<td>PR-32&#945; (atago-usa.com)</td>
			<td>To test the alcohol concentration of the infusate</td>
		</tr>
		<tr>
			<td>Griffin Powermate buttons</td>
			<td>CDW Government Inc.</td>
			<td></td>
			<td>Item was discontinued 2018; currently working on a replacement</td>
		</tr>
		<tr>
			<td>iMed Gemini PC-2TX Infusion Pump</td>
			<td>Soma Technology, Inc. or DiaMedical USA</td>
			<td>http://www.somatechnology.com/ OR https://diamedicalusa.com/medical-equipment/on-site-repairs-preventive-maintenance/infusion-pump-repair-service/alaris-infusion-pumps/alaris-imed-gemini-pc-2tx-infusion-pump-2/</td>
			<td>Infusion pump. Must contact company for a quote as product is not shown on the website.</td>
		</tr>
		<tr>
			<td>Laptop/Computer</td>
			<td>CDW Government Inc.</td>
			<td>https://www.cdwg.com/search/computers/laptops-2-in-1s/laptops/?w=CB2&#38;filter=af_system_notebook 
			_type_cb2_ss%3a(%22Notebook%22)</td>
			<td>OS, Windows 7 or newer (with updates installed); Administrative privileges; MS Office (including Excel); At least 3 usb ports on PC, and a port multiplier depending on actual experiment.</td>
		</tr>
		<tr>
			<td>Secure Dongle</td>
			<td>SecuTech</td>
			<td>https://esecutech.com/store/unikey/unikey-drive/unikey-drive-2gb</td>
			<td>For CAIS software and data storage</td>
		</tr>
		<tr>
			<td>StarTech.com 1 Port USB to RS232 DB9 Serial Adapter Cable - M/M</td>
			<td>CDW Government Inc.</td>
			<td>StarTech.com 1 Port USB to RS232 DB9 Serial Adapter Cable - M/M - ICUSB232V2 - - (cdwg.com)</td>
			<td>To connect laptop to IV pump</td>
		</tr>
		<tr>
			<td>StarTech.com 2 Port USB to RS-232 Serial DB9 Adapter Cable - Serial Adapter</td>
			<td>CDW Government Inc.</td>
			<td>StarTech.com 2 Port USB to RS-232 Serial DB9 Adapter Cable - Serial Adapter - ICUSB232C2 - - (cdwg.com)</td>
			<td>To connect laptop to IV pump</td>
		</tr>
		<tr>
			<td>StarTech.com DB9 to RJ45 Modular Adapter F F serial adaptor</td>
			<td>CDW Government Inc.</td>
			<td>https://www.cdwg.com/shop/products/StarTech.com-DB9-to-RJ45-Modular-Serial-Adapter-Black/386543.aspx?pfm=srh</td>
			<td>To connect laptop to IV pump</td>
		</tr>
		<tr>
			<td>StarTech.com DB9 to RJ45 Modular Adapter M F serial adaptor</td>
			<td>CDW Government Inc.</td>
			<td>https://www.cdwg.com/shop/products/StarTech.com-DB9-to-RJ45-Modular-Serial-Adapter-Black/386544.aspx?enkwrd=StarTech%20com%20DB9%20to%20RJ45%20Modular%20Adapter%20M%20F%20serial%20adapter&#38;pfm=srh</td>
			<td>To connect laptop to IV pump</td>
		</tr>
		<tr>
			<td>USB extension cable 12&#39;</td>
			<td>CDW Government Inc.</td>
			<td>https://www.cdwg.com/shop/products/StarTech.com-10ft-USB-2.0-Extension-Cable-A-to-A-Cable-Black/2274398.aspx?pfm=srh</td>
			<td>To connect and extend the button in reach of the participant</td>
		</tr>
		<tr>
			<td>VGA Cable 12&#39;</td>
			<td>BestBuy</td>
			<td>https://www.bestbuy.com/site/insignia-12-vga-cable-black/5884115.p?skuId=5884115</td>
			<td>To&#160; connect monitor to laptop</td>
		</tr>
	</tbody>
</table>

the motivation for alcohol reward: predictors of progressive-ratio intravenous alcohol self-administration in humans

The Progressive Ratio (PR) self-administration paradigm is a common pre-clinical method used to examine the motivation for a drug attributed to a craving, reward, or the relief of negative affect. The Computer-assisted Alcohol Infusion System (CAIS) enables intravenous alcohol self-administration behavior in humans. This system provides the investigator with control over the trajectory of each incremental breath alcohol concentration (BrAC) reward and the maximum BrAC allowed in a session. This paradigm allows participants to earn these alcohol rewards using a sequence of button presses specified by the investigator. The system employs a physiologically-based pharmacokinetic model-based algorithm to achieve the same incremental BrAC exposure in every participant. Participants (n = 11) took part in two identical sessions to examine test-retest reliability, and an additional group (n = 73) completed a single session. Sessions began with a 25 min priming phase: participants were instructed to press a button an increasing number of times per reward, accumulating four standardized incremental BrAC trajectories. The second phase comprised an ad-lib, PR paradigm lasting 125 min. Each reward required an increasing number of button presses. Measures of self-administration included: average and peak BrAC, total rewards earned, total grams of ethanol consumed per unit of total body water, the total number of button presses, and the average rate of button pressing. Self-administration measures were highly correlated both between and within sessions, demonstrating test-retest reliability and internal consistency. Recent drinking history was strongly associated with self-administration measures; heavier drinkers chose greater alcohol self-administration. These results indicate the reliability and sensitivity of this progressive-ratio intravenous alcohol self-administration method for assessing the motivational properties of alcohol, with the potential for improved testing of the efficacy of new medications thought to reduce consumption of alcohol. This method can be used to understand the genetic and environmental determinants of alcohol self-administration in humans.

Volunteers were pre-screened via telephone interview and brought in for an initial screening visit. A physical examination and medical history, blood tests for liver function and routine blood chemistry, and a urine screen for illegal drugs were conducted. Recent drinking history was assessed using the 90-day Timeline Followback (TLFB)31 and Alcohol Use Disorder Identification Test (AUDIT)32.
Participants were excluded if they have any clinically significant medical problems, use of prescription or over-the-counter (OTC) medication known to interact with alcohol in the past 2-4 weeks, lifetime or current diagnosis of substance or alcohol dependence; currently seeking treatment for alcohol use disorders; the presence of withdrawal symptoms that are clinically significant (a score &#62;8 on the Clinical Institute Withdrawal Assessment (CIWA))33, or pregnancy in women. Other IV alcohol administration studies have included participants with a lifetime diagnosis of alcohol dependence, as well as current if the participant is non-treatment seeking.
To better understand the role of alcohol expectancies on motivation for alcohol rewards, the Alcohol Effects Questionnaire (AEFQ)34 was administered. Additionally, subjective response measures were collected at baseline and serially during the study session to examine the urge for alcohol using the CAIS Experience Questionnaire (CEQ), Alcohol Urge Questionnaire (AUQ)35 and the effects of alcohol using the Drug Effects Questionnaire (DEQ)36. Measures of progressive ratio work include the total number of button presses across all rewards, the total number of false button presses (an incomplete attempt to press the button/or pressing faster than the maximal rate), total reward time (the amount of time spent pressing the button for alcohol), average rate of button pressing, and false button press fraction. Other measures included: peak BrAC, average BrAC, total rewards earned, and total ethanol consumed. These measures do not include the priming portion of the session.
Data were analyzed using General Linear Model Univariate to compare IV-ASA measures for males and females (Table 1) and Low Responders and High Responders (Table 2). Pearson&#39;s r correlational analyses were conducted to compare session 1 and session 2 IV-ASA measures (Figure 3) and IV-ASA measures with recent drinking history measures (Figure 4). Finally, General Linear Model Univariate analyses were conducted to compare Low and High Responders on measures of alcohol expectancies (Figure 5) and subjective response measures during the priming phase (Figure 6) and for peak subjective response scores (Figure 7).
One hundred and fifteen healthy, non-alcohol-dependent participants were recruited for this study. Sixteen participants were excluded due to availability issues, eight due to system crashes during 2nd infusion visit, six due to medical reasons (i.e., low blood pressure, fainting, etc.), and one from not meeting inclusion criteria (i.e., alcohol dependence diagnosis). Therefore, a total of 84 participants were used in the final analysis. The sample was 54.8% male (n = 46) and 67.9% identified as White/Caucasian (n = 57). Table 3 summarizes the demographics of the analytical sample.
Effects of sex differences were assessed on both drinking history measures as well as the session outcomes (Table 1). Females and males were not significantly different on recent drinking history measures as reported by the AUDIT and TLFB 90 Days. As for session measures, the only statistically significant sex difference was the total amount of EtOH consumed. This significant difference was expected given that males have larger total body water volumes of alcohol distribution than females, and these pharmacokinetic differences are adjusted for by the program. Sex was a covariant in all further analyses.
A subset of participants (N = 11) completed two identical sessions. Pearson&#39;s r correlation coefficients were calculated comparing session 1 and session 2 self-administration variables of peak BrAC, total rewards earned, the total number of button presses, and the average rate of button pressing. Pearson&#39;s r ranged from 0.81 to 0.96 (P &#8804; 0.002). There was a high test-retest reliability for the progressive ratio method for all self-administration measures (Figure 3). Correlation coefficients were also used to examine internal consistency among self-administration measures. Pearson&#39;s r ranged from 0.71 to 0.96 (p &#60; 0.01). As expected, the total number of rewards was strongly correlated with peak BrAC, average BrAC, and total EtOH infused (data not shown).
As expected, there was substantial variability in self-administration behavior (Figure 8). By comparing session data with recent drinking history, we found that the number of drinking days during the past 90 days was closely associated with drinking behaviors in the lab (Figure 4). These associations include regular measures such as peak BrAC, average BrAC (not shown in the figure), and total EtOH. The system-specific measures such as average rate and false button presses fraction were also associated with recent drinking history measures. Pearson&#39;s r ranged from 0.257 to 0.314 (p &#8804; 0.025).
To evaluate the relationship between alcohol-seeking behavior and subjective responses throughout the session, a median split (median = 5) was conducted on total rewards earned, yielding 2 groups labeled low responders and high responders. High responders had significantly higher drinking history measures of Total Drinks over the past 90 days and Number of Heavy Drinking Days over the past 90 days (Table 2). As expected, higher responders pressed a significantly greater number of times for infusions during the session than low responders and spent more time working for those rewards (all p&#39;s &#60; 0.001). Subjective responses were analyzed by comparing group means at baseline during the PR priming phase as during the PR self-administration phase. Low responders reported more overall negative expectancies of alcohol (p = 0.023) at baseline, including expectations of cognitive and physical impairment (p = 0.022) (Figure 5).
During the priming phase, low and high responders were significantly different on both CEQ and DEQ measures (Figure 6). High responders would have been willing to pay more money for their next drink (p = 0.038). Low responders felt the alcohol more after priming (p = 0.001) and felt more intoxicated following priming (p &#60; 0.001).
During the open bar PR phase, high and low responders were significantly different on DEQ measures of &#34;liking&#34; (p = 0.014) and &#34;wanting&#34; (p = 0.001) alcohol (Figure 7). High responders had a higher craving for alcohol, as seen in the AUQ total score (p = 0.003). They were also still willing to pay more for their next drink at the end of the open bar PR phase (p &#60; 0.001).
<img alt="Figure 1" class="xfigimg" src="/files/ftp_upload/63576/63576fig01.jpg" /> 
Figure 1: Test session set-up of materials. Schematic of the set-up of IV pump, work button, laptop, and data entry screen from the software. <a href="https://www.jove.com/files/ftp_upload/63576/63576fig01large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 2" class="xfigimg" src="/files/ftp_upload/63576/63576fig02.jpg" /> 
Figure 2: Timeline of events. Timeline of the priming session, ad-lib session, and measures collected. <a href="https://www.jove.com/files/ftp_upload/63576/63576fig02large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 3" class="xfigimg" src="/files/ftp_upload/63576/63576fig03.jpg" /> 
Figure 3: Test-retest reliability in n = 11 subjects undertaking 2 identical sessions. Session 1 is on the x-axis, and session 2 is on the y-axis. There were statistically significant correlations between session 1 and session 2 drinking measures for: peak BrAC, total rewards earned, the total number of button presses, and average rate of button pressing. <a href="https://www.jove.com/files/ftp_upload/63576/63576fig03large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 4" class="xfigimg" src="/files/ftp_upload/63576/63576fig04.jpg" /> 
Figure 4: Recent drinking history and session measures. Graphical representation of the statistically significant relationship between past drinking history using the 90-day Timeline Followback (TLFB) and drinking measures during the self-administration session. <a href="https://www.jove.com/files/ftp_upload/63576/63576fig04large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 5" class="xfigimg" src="/files/ftp_upload/63576/63576fig05.jpg" /> 
Figure 5: Alcohol expectancies. Alcohol expectancies at baseline were significantly different between low versus high responders. Low responders expected more overall negative effects from alcohol at baseline and, specifically, greater cognitive and physical impairment as a result of alcohol. *p &#60; 0.05 <a href="https://www.jove.com/files/ftp_upload/63576/63576fig05large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 6" class="xfigimg" src="/files/ftp_upload/63576/63576fig06.jpg" /> 
Figure 6: Subjective response following priming phase. Subjective response at the 20 min mark was significantly different between low versus high responders. High responders were willing to pay more for their next drink after priming, as indicated by the CEQ. Low responders felt the alcohol more directly after priming and felt more intoxicated, as indicated by the DEQ. *p &#60; 0.05; **p &#60; 0.01; ***p &#60; 0.001 <a href="https://www.jove.com/files/ftp_upload/63576/63576fig06large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 7" class="xfigimg" src="/files/ftp_upload/63576/63576fig07.jpg" /> 
Figure 7: Subjective response during progressive-ratio open bar phase. Subjective response during the open bar phase was significantly different between low versus high responders. High responders reported higher peak scores for liking alcohol and wanting alcohol on the DEQ. They also reported higher peak craving or urge for alcohol on the AUQ. High responders were willing to pay more for their next drink at the end of the open-bar phase, as indicated by the CEQ. *p &#60; 0.05; **p &#60; 0.01; ***p &#60; 0.001 <a href="https://www.jove.com/files/ftp_upload/63576/63576fig07large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 8" class="xfigimg" src="/files/ftp_upload/63576/63576fig08.jpg" /> 
Figure 8: BrAC trajectories. The graphs document the predicted BrAC trajectories during the entire session (including the priming phase). At the 10 min mark, most participants achieved a 30 mg/dL BrAC, which was the desired BrAC for the priming phase. The variability in the self-administration phase reflects the sensitivity of the paradigm to differences across participants. <a href="https://www.jove.com/files/ftp_upload/63576/63576fig08large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td></td>
			<td>Females (N = 38)</td>
			<td>Males (N = 46)</td>
		</tr>
		<tr>
			<td>Drinking History:</td>
			<td></td>
			<td></td>
		</tr>
		<tr>
			<td>Total Drinks</td>
			<td>92.8 &#177; 120.7</td>
			<td>93.9 &#177; 72.9</td>
		</tr>
		<tr>
			<td>Drinking Days</td>
			<td>25.1 &#177; 12.9</td>
			<td>27.7 &#177; 14.3</td>
		</tr>
		<tr>
			<td>Drinks per Day</td>
			<td>3.3 &#177; 2.3</td>
			<td>3.4 &#177; 1.6</td>
		</tr>
		<tr>
			<td>Heavy Drinking Days</td>
			<td>8.9 &#177; 11.5</td>
			<td>6.4 &#177; 9.1</td>
		</tr>
		<tr>
			<td>Session Measures:</td>
			<td></td>
			<td></td>
		</tr>
		<tr>
			<td>Peak BrAC</td>
			<td>34.6 &#177; 17.7</td>
			<td>37.9 &#177; 21.0</td>
		</tr>
		<tr>
			<td>Average BrAC</td>
			<td>21.4 &#177; 15.6</td>
			<td>23.3 &#177; 18.7</td>
		</tr>
		<tr>
			<td>Total Rewards Earned</td>
			<td>5.4 &#177; 3.3</td>
			<td>5.5 &#177; 3.8</td>
		</tr>
		<tr>
			<td>Total EtOH consumed (grams) **</td>
			<td>16.8 &#177; 7.6</td>
			<td>25.6 &#177; 15.0</td>
		</tr>
		<tr>
			<td>Number of Button Presses</td>
			<td>2035.2 &#177; 2657.1</td>
			<td>2940.7 &#177; 5179.5</td>
		</tr>
		<tr>
			<td>Number of False Button Presses</td>
			<td>445.7 &#177; 828.2</td>
			<td>585.0 &#177; 1112.4</td>
		</tr>
		<tr>
			<td>Total Reward Time</td>
			<td>1146.9 &#177; 1277.3</td>
			<td>1460.0 &#177; 1643.3</td>
		</tr>
		<tr>
			<td>Average Rate of Button Pressing</td>
			<td>1.9 &#177; 1.1</td>
			<td>2.3 &#177; 1.6</td>
		</tr>
		<tr>
			<td>False Button Presses Fraction</td>
			<td>0.12 &#177; 0.12</td>
			<td>0.16 &#177; 0.14</td>
		</tr>
		<tr>
			<td>False Button Presses Fraction</td>
			<td>0.12 &#177; 0.12</td>
			<td>0.16 &#177; 0.14</td>
		</tr>
	</tbody>
</table>
Table 1: Sex differences in drinking measures. The first panel reports 90 Day Timeline Followback (TLFB) measures. Males and females were not significantly different (p &#62; 0.05) on any drinking history measures, indicating that they drank similarly outside the lab. The second panel shows session consumption measures. Males and females were significantly different only on the total amount of ethanol consumed (**p = 0.005). This difference is commensurate with sex differences in total body water and likely reflects the difference in consumption needed to achieve comparable peak BrACs.
<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td></td>
			<td>Low Responders (N = 45)</td>
			<td>High Responders (N = 39)</td>
		</tr>
		<tr>
			<td>Drinking History:</td>
			<td></td>
			<td></td>
		</tr>
		<tr>
			<td>Total Drinks*</td>
			<td>73.5 &#177; 48.4</td>
			<td>116.4 &#177; 129.4</td>
		</tr>
		<tr>
			<td>Drinking Days</td>
			<td>24.8 &#177; 13.6</td>
			<td>28.7 &#177; 13.7</td>
		</tr>
		<tr>
			<td>Drinks per Day</td>
			<td>3.2 &#177; 1.6</td>
			<td>3.7 &#177; 2.3</td>
		</tr>
		<tr>
			<td>Heavy Drinking Days*</td>
			<td>5.7 &#177; 7.4</td>
			<td>9.6 &#177; 12.6</td>
		</tr>
		<tr>
			<td>Session Measures:</td>
			<td></td>
			<td></td>
		</tr>
		<tr>
			<td>Peak BrAC**</td>
			<td>26.4 &#177; 12.4</td>
			<td>&#160;47.9 &#177; 20.0</td>
		</tr>
		<tr>
			<td>Average BrAC**</td>
			<td>12.6 &#177; 9.5</td>
			<td>33.8 &#177; 17.4</td>
		</tr>
		<tr>
			<td>Total Rewards Earned**</td>
			<td>2.5 &#177; 1.6</td>
			<td>8.7 &#177; 1.9</td>
		</tr>
		<tr>
			<td>Total EtOH consumed (g) **</td>
			<td>15.2 &#177; 6.6</td>
			<td>29.1 &#177; 14.4</td>
		</tr>
		<tr>
			<td>Number of Button Presses**</td>
			<td>225.1 &#177; 242.1</td>
			<td>5191.8 &#177; 5046.0</td>
		</tr>
		<tr>
			<td>Number of False Button Presses**</td>
			<td>37.9 &#177; 75.3</td>
			<td>1080.5 &#177; 1240.9</td>
		</tr>
		<tr>
			<td>Total Reward Time (s)**</td>
			<td>386.4 &#177; 961.3</td>
			<td>2393.7 &#177; 1246.9</td>
		</tr>
		<tr>
			<td>Average Rate of Button Pressing**</td>
			<td>1.7 &#177; 1.4</td>
			<td>2.6 &#177; 1.4</td>
		</tr>
		<tr>
			<td>False Button Presses Fraction**</td>
			<td>0.09 &#177; 0.11</td>
			<td>0.20 &#177; 0.13</td>
		</tr>
	</tbody>
</table>
Table 2: Low and high responder differences in drinking history measures. The table reports 90 Day Timeline Followback (TLFB) measures and intravenous self-administration measures (IV-ASA). Low Responders and High Responders were significantly different on Total Drinks and Number of Heavy Drinking Days (all p&#39;s &#60; 0.05). These differences indicate that these participants have different drinking histories that were also reflected in their PR behavior in the laboratory. Low Responders had significantly lower IV-ASA measures than High Responders (all p&#39;s &#60; 0.001).
<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td>Construct</td>
			<td></td>
			<td>Mean &#177; S.D. (Percentage)</td>
		</tr>
		<tr>
			<td>Sex</td>
			<td>Female</td>
			<td>38 (45.2%)</td>
		</tr>
		<tr>
			<td></td>
			<td>Male</td>
			<td>46 (54.8%)</td>
		</tr>
		<tr>
			<td>Race</td>
			<td>White</td>
			<td>57 (67.9%)</td>
		</tr>
		<tr>
			<td></td>
			<td>African American/Black</td>
			<td>12 (14.3%)</td>
		</tr>
		<tr>
			<td></td>
			<td>Asian</td>
			<td>9 (10.7%)</td>
		</tr>
		<tr>
			<td></td>
			<td>Mixed Race</td>
			<td>5 (6.0%)</td>
		</tr>
		<tr>
			<td></td>
			<td>Unknown</td>
			<td>1 (1.2%)</td>
		</tr>
		<tr>
			<td>Age</td>
			<td></td>
			<td>24.8 &#177; 3.0</td>
		</tr>
		<tr>
			<td>Years of Education</td>
			<td></td>
			<td>15.9 &#177; 3.0</td>
		</tr>
		<tr>
			<td>Household Income</td>
			<td>Median</td>
			<td>$30,000&#8211;$39,999</td>
		</tr>
	</tbody>
</table>
Table 3: Demographics of the analytical sample. This table gives a breakdown of the characteristics of our sample.

Watch this Scientific Journal Video about The Motivation for Alcohol Reward: Predictors of Progressive-Ratio Intravenous Alcohol Self-Administration in Humans at JoVE.com

The Motivation for Alcohol Reward: Predictors of Progressive-Ratio Intravenous Alcohol Self-Administration in Humans

This study aims to show that the Progressive-Ratio Computer-assisted Alcohol-Infusion System (CAIS) paradigm is a reliable and sensitive method that can be used to examine the motivating properties associated with alcohol self-administration in humans.

The Progressive Ratio (PR) self-administration paradigm is a common pre-clinical method used to examine the motivation for a drug attributed to a craving, ...

the-motivation-for-alcohol-reward-predictors-progressive-ratio

Research

JoVE Journal

Behavior

2.9K Views.  NIAAA. This study aims to show that the Progressive-Ratio Computer-assisted Alcohol-Infusion System (CAIS) paradigm is a reliable and sensitive method that can be used to examine the motivating properties associated with alcohol self-administration in humans.

Video: The Motivation for Alcohol Reward: Predictors of Progressive-Ratio Intravenous Alcohol Self-Administration in Humans

A Novel Procedure for Evaluating the Reinforcing Properties of Tastants in Laboratory Rats: Operant Intraoral Self-administration

This paper describes a novel method for studying the bio-behavioral basis of addiction to food. This method combines the surgical component of taste reactivity with the behavioral aspects of operant self-administration of drugs. Under very brief general anaesthesia, rats are implanted with an intraoral (IO) cannula that allows delivery of test solutions directly in the oral cavity. Animals are then tested in operant self-administration chambers whereby they can press a lever to receive IO infusions of test solutions. IO self-administration has several advantages over experimental procedures that involve drinking a solution from a spout&#160;or operant responding for solid pellets or solutions delivered in a receptacle. Here, we show that IO self-administration can be employed to study self-administration of high fructose corn syrup (HFCS). Rats were first tested for self-administration on a progressive ratio (PR) schedule, which assesses the maximum amount of operant behavior that will be emitted for different concentrations of HFCS (i.e.&#160;8%, 25%, and 50%). Following this test, rats self-administered these concentrations on a continuous schedule of reinforcement (i.e.&#160;one infusion for each lever press) for 10 consecutive days (1 session/day; each lasting 3 hr), and then they were retested on the PR schedule. On the continuous reinforcement schedule, rats took fewer infusions of higher concentrations, although the lowest concentration of HFCS (8%) maintained more variable self-administration. Furthermore, the PR tests revealed that 8% had lower reinforcing value than 25% and 50%. These results indicate that IO self-administration can be employed to study acquisition and maintenance of responding for sweet solutions. The sensitivity of the operant response to differences in concentration and schedule of reinforcement makes IO self-administration an ideal procedure to investigate the neurobiology of voluntary intake of sweets.

The current study evaluates a novel procedure for assessing the reinforcing effects of palatable solutions in laboratory rats: intraoral self-administration. To this end, operant responding (i.e.&#160;lever pressing) for intraoral infusions of sweet solutions at different concentrations was measured on continuous and progressive ratios schedules of reinforcement.

This paper describes a novel method for studying the bio-behavioral basis of addiction to food. This method combines the surgical component of taste ...

Studying Food Reward and Motivation in Humans

A key challenge in studying reward processing in humans is to go beyond subjective self-report measures and quantify different aspects of reward such as hedonics, motivation, and goal value in more objective ways. This is particularly relevant for the understanding of overeating and obesity as well as their potential treatments. In this paper are described a set of measures of food-related motivation using handgrip force as a motivational measure. These methods can be used to examine changes in food related motivation with metabolic (satiety) and pharmacological manipulations and can be used to evaluate interventions targeted at overeating and obesity. However to understand food-related decision making in the complex food environment it is essential to be able to ascertain the reward goal values that guide the decisions and behavioral choices that people make. These values are hidden but it is possible to ascertain them more objectively using metrics such as the willingness to pay and a method for this is described. Both these sets of methods provide quantitative measures of motivation and goal value that can be compared within and between individuals.

This article describes a set of methods for the measurement of food related motivation and food related goal values in humans.

A key challenge in studying reward processing in humans is to go beyond subjective self-report measures and quantify different aspects of reward such as ...

A Procedure to Observe Context-induced Renewal of Pavlovian-conditioned Alcohol-seeking Behavior in Rats

Environmental contexts in which drugs of abuse are consumed can trigger craving, a subjective Pavlovian-conditioned response that can facilitate drug-seeking behavior and prompt relapse in abstinent drug users. We have developed a procedure to study the behavioral and neural processes that mediate the impact of context on alcohol-seeking behavior in rats. Following acclimation to the taste and pharmacological effects of 15% ethanol in the home cage, male Long-Evans rats receive Pavlovian discrimination training (PDT) in conditioning chambers. In each daily (Mon-Fri) PDT session, 16 trials each of two different 10 sec auditory conditioned stimuli occur. During one stimulus, the CS+, 0.2 ml of 15% ethanol is delivered into a fluid port for oral consumption. The second stimulus, the CS-, is not paired with ethanol. Across sessions, entries into the fluid port during the CS+ increase, whereas entries during the CS- stabilize at a lower level, indicating that a predictive association between the CS+ and ethanol is acquired. During PDT each chamber is equipped with a specific configuration of visual, olfactory and tactile contextual stimuli. Following PDT, extinction training is conducted in the same chamber that is now equipped with a different configuration of contextual stimuli. The CS+ and CS- are presented as before, but ethanol is withheld, which causes a gradual decline in port entries during the CS+. At test, rats are placed back into the PDT context and presented with the CS+ and CS- as before, but without ethanol. This manipulation triggers a robust and selective increase in the number of port entries made during the alcohol predictive CS+, with no change in responding during the CS-. This effect, referred to as context-induced renewal, illustrates the powerful capacity of contexts associated with alcohol consumption to stimulate alcohol-seeking behavior in response to Pavlovian alcohol cues.

A procedure to study the capacity of an alcohol associated environmental context to trigger the renewal of alcohol-seeking behavior in rats is described.

Environmental contexts in which drugs of abuse are consumed can trigger craving, a subjective Pavlovian-conditioned response that can facilitate ...

Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats

Alterations in social behavior are among the major negative consequences observed in children with Fetal Alcohol Spectrum Disorders (FASDs). Several independent laboratories have demonstrated robust alterations in the social behavior of rodents exposed to alcohol during brain development across a wide range of exposure durations, timing, doses, and ages at the time of behavioral quantification. Prior work from this laboratory has identified reliable alterations in specific forms of social interaction following moderate prenatal alcohol exposure (PAE) in the rat that persist well into adulthood, including increased wrestling and decreased investigation. These behavioral alterations have been useful in identifying neural circuits altered by moderate PAE1, and may hold importance for progressing toward a more complete understanding of the neural bases of PAE-related alterations in social behavior. This paper describes procedures for performing moderate PAE in which rat dams voluntarily consume ethanol or saccharin (control) throughout gestation, and measurement of social behaviors in adult offspring.

The goal of the protocol presented here is to describe procedures to expose rats to moderate levels of alcohol during prenatal brain development and to quantify resulting alterations in social behavior during adulthood.

Alterations in social behavior are among the major negative consequences observed in children with Fetal Alcohol Spectrum Disorders (FASDs). Several ...

Quantifying Social Motivation in Mice Using Operant Conditioning

In this protocol, social motivation is measured in mice through a pair of operant conditioning paradigms. To conduct the experiments, two-chambered shuttle boxes were equipped with two operant levers (left and right) and a food receptacle in one chamber, which was then divided from the second chamber by an automated guillotine door covered by a wire grid. Different stimulus mice, rotated across testing days, served as a social stimulus behind the wire grid, and were only visible following the opening of the guillotine door. Test mice were trained to lever press in order to open the door and gain access to the stimulus partner for 15 sec. The number of lever presses required to obtain the social reward progressively increased on a fixed schedule of 3. Testing sessions ended after test mice stopped lever pressing for 5 consecutive minutes. The last reinforced ratio or breakpoint can be used as a quantitative measure of social motivation. For the second paradigm, test mice were trained to discriminate between left and right lever presses in order to obtain either a food reward or the social reward. Mice were rewarded for every 3 presses of each respective lever. The number of food and social rewards can be compared as a measurement of the value placed upon each reward. The ratio of each reward type can also be compared between mouse strains and the change in this ratio can be monitored within testing sessions to measure satiation with a given reward type. Both of these operant conditioning paradigms are highly useful for the quantification of social motivation in mouse models of autism and other disorders of social behavior.

This article describes a new protocol for the quantitative measurement of social motivation in mice using operant conditioning for a social reward. The protocol is useful for the measurement of social motivation in mouse models of autism and other disorders of social behavior.

In this protocol, social motivation is measured in mice through a pair of operant conditioning paradigms. To conduct the experiments, two-chambered ...

Rodent Brain Microinjection to Study Molecular Substrates of Motivated Behavior

Brain microinjection can aid elucidation of the molecular substrates of complex behaviors, such as motivation. For this purpose rodents can serve as appropriate models, partly because the response to behaviorally relevant stimuli and the circuitry parsing stimulus-action outcomes is astonishingly similar between humans and rodents. In studying molecular substrates of complex behaviors, the microinjection of reagents that modify, augment, or silence specific systems is an invaluable technique. However, it is crucial that the microinjection site is precisely targeted in order to aid interpretation of the results. We present a method for the manufacture of surgical implements and microinjection needles that enables accurate microinjection and unlimited customizability with minimal cost. Importantly, this technique can be successfully completed in awake rodents if conducted in conjunction with other JoVE articles that covered requisite surgical procedures. Additionally, there are many behavioral paradigms that are well suited for measuring motivation. The progressive ratio is a commonly used method that quantifies the efficacy of a reinforcer to maintain responding despite an (often exponentially) increasing work requirement. This assay is sensitive to reinforcer magnitude and pharmacological manipulations, which allows reinforcing efficacy and/ or motivation to be determined. We also present a straightforward approach to program operant software to accommodate a progressive ratio reinforcement schedule.

Rodents are an appropriate model to investigate the molecular substrates of behavior and complex psychiatric disorders. Brain microinjection in awake rodents can be used to elucidate disease substrates. An efficient and customizable brain microinjection method as well as the execution of an operant paradigm that quantifies motivation is presented.

Brain microinjection can aid elucidation of the molecular substrates of complex behaviors, such as motivation. For this purpose rodents can serve as ...

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Substance use disorders, particularly to methamphetamine, are devastating, relapsing diseases that disproportionally affect young people. There is a need for novel, effective and practical treatment strategies that are validated in animal models. Neuromodulation, including deep brain stimulation (DBS) therapy, refers to the use of electricity to influence pathological neuronal activity and has shown promise for psychiatric disorders, including drug dependence. DBS in clinical practice involves the continuous delivery of stimulation into brain structures using an implantable pacemaker-like system that is programmed externally by a physician to alleviate symptoms. This treatment will be limited in methamphetamine users due to challenging psychosocial situations. Electrical treatments that can be delivered intermittently, non-invasively and remotely from the drug-use setting will be more realistic. This article describes the delivery of intracranial electrical stimulation that is temporally and spatially separate from the drug-use environment for the treatment of IV methamphetamine dependence. Methamphetamine dependence is rapidly developed in rodents using an operant paradigm of intravenous (IV) self-administration that incorporates a period of extended access to drug and demonstrates both escalation of use and high motivation to obtain drug.

This article describes the delivery of intracranial electrical stimulation that is temporally and spatially separate from the drug-use environment for the treatment of IV methamphetamine dependence.

Substance use disorders, particularly to methamphetamine, are devastating, relapsing diseases that disproportionally affect young people.  There is a need ...

Force and Position Control in Humans - The Role of Augmented Feedback

During motor behaviour, humans interact with the environment by for example manipulating objects and this is only possible because sensory feedback is constantly integrated into the central nervous system and these sensory inputs need to be weighted in order meet the task specific goals. Additional feedback presented as augmented feedback was shown to have an impact on motor control and motor learning. A number of studies investigated whether force or position feedback has an influence on motor control and neural activation. However, as in the previous studies the presentation of the force and position feedback was always identical, a recent study assessed whether not only the content but also the interpretation of the feedback has an influence on the time to fatigue of a sustained submaximal contraction and the (inhibitory) activity of the primary motor cortex using subthreshold transcranial magnetic stimulation. This paper describes one possible way to investigate the influence of the interpretation of feedback on motor behaviour by investigating the time to fatigue of submaximal sustained contractions together with the neuromuscular adaptations that can be investigated using surface EMG. Furthermore, the current protocol also describes how motor cortical (inhibitory) activity can be investigated using subthreshold TMS, a method known to act solely on the cortical level. The results show that when participants interpret the feedback as position feedback, they display a significantly shorter time to fatigue of a submaximal sustained contraction. Furthermore, subjects also displayed an increased inhibitory activity of the primary cortex when they believed to receive position feedback compared when they believed to receive force feedback. Accordingly, the results show that interpretation of feedback results in differences on a behavioural level (time to fatigue) that is also reflected in interpretation-specific differences in the amount of inhibitory M1 activity.

Controlling an identical movement with position or force feedback results in different neural activation and motor behavior. This protocol describes how to investigate behavioral changes by looking at neuromuscular fatigue and how to evaluate motor cortical (inhibitory) activity using subthreshold TMS with respect to the interpretation of augmented feedback.

During motor behaviour, humans interact with the environment by for example manipulating objects and this is only possible because sensory feedback is ...

A Method for Evaluating the Reinforcing Properties of Ethanol in Rats without Water Deprivation, Saccharin Fading or Extended Access Training

Operant oral self-administration methods are commonly used to study the reinforcing properties of ethanol in animals. However, the standard methods require saccharin/sucrose fading, water deprivation and/or extended training to initiate operant responding in rats. This paper describes a novel and efficient method to quickly initiate operant responding for ethanol that is convenient for experimenters and does not require water deprivation or saccharin/sucrose fading, thus eliminating the potential confound of using sweeteners in ethanol operant self-administration studies. With this method, Wistar rats typically acquire and maintain self-administration of a 20% ethanol solution in less than two weeks of training. Furthermore, blood ethanol concentrations and rewards are positively correlated for a 30 min self-administration session. Moreover, naltrexone, an FDA-approved medication for alcohol dependence that has been shown to suppress ethanol self-administration in rodents, dose-dependently decreases alcohol intake and motivation to consume alcohol for rats self-administering 20% ethanol, thus validating the use of this new method to study the reinforcing properties of alcohol in rats.

This protocol describes a novel and efficient method to quickly initiate operant responding for ethanol in rats that, contrary to standard methods, does not require water deprivation or saccharin/sucrose fading to initiate responding.

Operant oral self-administration methods are commonly used to study the reinforcing properties of ethanol in animals. However, the standard methods ...

A Conflict Model of Reward-seeking Behavior in Male Rats

The present protocol describes a novel conflict task as a model of inhibitory control in rats. In this model, a natural rewarding stimulus (sexual stimulus) that represents a high-value reward, and the aversive stimuli (pins), are concurrently presented. The male rats have to climb or jump over the obstacle full of pins to approach and investigate the sexual partner. If the animal persists in their approaching behavior regardless of the aversive stimuli, it is considered as a maladaptive or risky reward-seeking behavior. The conflict task permits the evaluation of deficit in inhibitory control resulting from exposure to abused drug, such as morphine, or a stressful event. 
The main advantage of this model is that it provides a simple and quick way to discover the deficit in inhibitory control after exposure to opiate drugs or other stressful events. In addition to opiates, this behavioral model would also be useful for quickly discovering the inhibitory control deficits induced by other addictive drugs. However, the limitation is that the male rats' performance may be subject to exercising effects with repeated testing under this conflict task. In the future, one can hope that the individuals with the compulsive phenotype of reward-seeking behavior after exposure to opiates will be identified based on modifying this conflict model.

This conflict model is used to measure the impairment of inhibitory control after exposure to addictive drugs, or other factors that may influence inhibitory control. A sexual stimulus and an aversive obstacle are concurrently presented, thus male rats have to conquer the obstacle to approach the sexual reward.